Cytochrome P450 3A-mediated metabolic activation of fibleucin from Tinospora sagittata initiates liver injury in mice
Drug Metabolism and Disposition · 2026-08 · 54 (8) · 100345
DOI: 10.1016/j.dmd.2026.100345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-08. Verfasst von Jie Dai und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine (TCM), Engineering Research Center for the…. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Cytochrome P-450 CYP3A, Tinospora. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Guizhou Medical University.
Abstract (Originalsprache)
TINOSPORA: sagittata is a widely used medicinal herb whose safety has raised increasing concerns in recent years. Fibleucin (FBL), a furanoditerpenoid isolated from T sagittata, has not been systematically evaluated for its safety and toxicological mechanisms despite its presence as a major bioactive constituent in this medicinal plant. To address this toxicological knowledge gap, we comprehensively investigated the hepatotoxicity and/or metabolic activation of FBL in vivo (mice) and in vitro (mouse and human liver microsomal incubations as well as primary mouse hepatocytes). Oral administration of FBL (single intragastric dose) dose-dependently elevated serum alanine transaminase, aspartate transaminase, alkaline phosphatase, blood ammonia, and total bile acid levels in mice, accompanied by hepatocellular degeneration, necrosis, and inflammatory infiltration. Pretreatment with the cytochrome P450 3A inhibitor ketoconazole (100 mg/kg) markedly alleviated the liver injury induced by FBL. Liquid chromatography-tandem mass spectrometry analysis of mouse liver microsomal incubations and primary hepatocyte exposure (1.0-50 μM FBL) revealed that FBL was bioactivated to an electrophilic intermediate reactive to thiols and amines. Similar observation was obtained in human liver microsomal incubations. The reactive intermediate was found to react with nucleophilic sites of hepatic glutathione and proteins to form the corresponding conjugates and adducts. The observed adduction correlated with the liver injury and cytotoxicity induced by FBL. Chemical synthesis was carried out to probe the mechanism of toxic action. The mechanistic investigation suggests that FBL was metabolized to the corresponding cis-2-butene-1,4-dial intermediate responsible for the glutathione depletion and protein adduction. SIGNIFICANCE STATEMENT: Tinospora sagittata is widely used, however, its hepatotoxic principles remain undefined. This study identifies fibleucin as a previously unrecognized hepatotoxic constituent and demonstrates that it undergoes cytochrome P450 3A-mediated metabolic activation to generate a reactive intermediate consistent with cis-2-butene-1,4-dial, leading to glutathione depletion and hepatic protein adduction. These findings establish a mechanistic link between bioactivation of a herbal constituent and liver injury, highlighting metabolic risk in furanoditerpenoid-containing traditional medicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine (TCM), Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of E…
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China. Electronic address: yingpeng1999@163.com.
Förderung
- Guizhou Medical University
Zitieren
APA
Dai, J., Liao, Y., Cheng, X., Zhang, Q., Ye, T., Yang, D., Zhang, C., Peng, Y., Li, W., & Zheng, J. (2026). Cytochrome P450 3A-mediated metabolic activation of fibleucin from Tinospora sagittata initiates liver injury in mice. Drug Metabolism and Disposition, 54(8), 100345. https://doi.org/10.1016/j.dmd.2026.100345
Vancouver
Dai J, Liao Y, Cheng X, Zhang Q, Ye T, Yang D, et al. Cytochrome P450 3A-mediated metabolic activation of fibleucin from Tinospora sagittata initiates liver injury in mice. Drug Metabolism and Disposition. 2026;54(8):100345. doi:10.1016/j.dmd.2026.100345
BibTeX
@article{Dai2026,
author = {Dai, Jie and Liao, Yufen and Cheng, Xueqian and Zhang, Qing and Ye, Tingmin and Yang, Dandan and Zhang, Chunlei and Peng, Ying and Li, Weiwei and Zheng, Jiang},
title = {Cytochrome P450 3A-mediated metabolic activation of fibleucin from Tinospora sagittata initiates liver injury in mice},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {8},
pages = {100345},
doi = {10.1016/j.dmd.2026.100345}
}
EUVIMED